Physician profile
David Bello
NPI 1043267958
$41,517.78
in general payments reported to CMS, 2019-2025
41 companies · $17K in 2025
The $17K reported for 2025 was more than what 87% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,728 · 2020: $1,649 · 2021: $1,351 · 2022: $7,442 · 2023: $5,800 · 2024: $4,588 · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $14K · Food and Beverage: $11K · Consulting Fee: $2,450 · Gift: $53.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $13,905.51 |
| Food and Beverage | $10,938.89 |
| Consulting Fee | $2,450.00 |
| Gift | $53.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $28,116.69 | 2019-2025 | Biomonitor, Acticor 7 Vr-T Dx, Amvia Edge |
| Abbott Laboratories | $4,770.47 | 2019-2025 | Confirm Rx, Aveir, Jot Dx |
| Kestra Medical Technology Services, INC. | $2,219.30 | 2023-2025 | Assure Wcd |
| Atricure, INC. | $743.98 | 2020-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Boston Scientific Corporation | $703.26 | 2022-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System, Bodyguardian |
| Medtronic, INC. | $494.18 | 2021-2025 | Pulseselect, Corevalve Evolut R, Linq II |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $443.30 | 2020-2025 | Lifevest |
| Biosense Webster, INC. | $437.84 | 2022 | |
| Astellas Pharma US INC | $396.00 | 2019-2021 | |
| Shockwave Medical, INC | $313.52 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $218.17 | 2024-2025 | Impella |
| Cardiva Medical, INC. | $198.48 | 2019-2020 | |
| Philips North America LLC | $187.89 | 2022-2024 | (5091) Amb Mon & Diag Und |
| Pfizer INC. | $183.36 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $180.24 | 2023-2025 | Wainua, Farxiga |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $174.14 | 2019-2024 | Xarelto |
| Alnylam Pharmaceuticals INC. | $164.99 | 2024-2025 | Onpattro |
| Novartis Pharmaceuticals Corporation | $160.26 | 2023-2025 | |
| Ethicon US, LLC | $153.57 | 2021 | |
| Penumbra, INC. | $153.42 | 2025 | Penumbra System |
| Medtronic Vascular, INC. | $152.34 | 2019-2020 | |
| Novo Nordisk INC | $152.00 | 2023-2024 | Ozempic |
| Elutia, INC. | $140.60 | 2021-2022 | |
| Cvrx, INC. | $101.81 | 2024-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $79.50 | 2022-2025 | Camzyos |
| Impulse Dynamics (USA) INC. | $62.16 | 2022-2023 | Optimizer |
| Amgen INC. | $60.13 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $54.38 | 2024 | Verquvo |
| Acarix USA INC. | $48.12 | 2024 | Cadscor System |
| Sensible Medical Innovations INC | $34.71 | 2022 | |
| Esperion Therapeutics, INC. | $33.96 | 2024-2025 | Nexletol |
| Kiniksa Pharmaceuticals International, Plc | $26.57 | 2024 | Arcalyst |
| Ge Healthcare | $25.18 | 2025 | |
| Kiniksa Pharmaceuticals, Ltd. | $23.41 | 2023 | Arcalyst |
| Innovation Technologies INC | $20.92 | 2021 | |
| Cordis US Corp. | $18.59 | 2025 | Mynx Control Venous |
| Genzyme Corporation | $16.42 | 2024 | |
| Scpharmaceuticals INC. | $15.78 | 2024 | |
| Sanofi-Aventis U.S. LLC | $12.90 | 2023 | |
| Baxter Healthcare | $12.89 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Convatec INC. | $12.35 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.